Found: 6
Select item for more details and to access through your institution.
Correction to: Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 8, p. 1622, doi. 10.1002/acn3.51411
- By:
- Publication type:
- Article
Switching therapies: safety profile of Onasemnogene abeparvovec-xioi in a SMA1 patient previously treated with Risdiplam.
- Published in:
- Acta Myologica, 2022, v. 41, n. 3, p. 117
- By:
- Publication type:
- Article
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 8, p. 1, doi. 10.1111/ene.16309
- By:
- Publication type:
- Article
Type I spinal muscular atrophy patients treated with nusinersen: 4‐year follow‐up of motor, respiratory and bulbar function.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 6, p. 1755, doi. 10.1111/ene.15768
- By:
- Publication type:
- Article